PATENT CLAIM ANALYSIS

Application Number: 15761277
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "093200"]

Abstract:
The instant invention comprises Trappin-2 expressed through stable integration into the genome of a lactic acid bacteria useful in the treatment of diseases characterized by damaging elastolytic activity, or bacterial infection.

Claim (Index 10):
The method for manufacturing trappin-2 according to  claim 9 , wherein said means for manufacturing the lactic acid bacteria sees the survival of said trappin-2 expressing lactic acid bacteria being greater than about 10-20% of the potential finished product of a preparation of second lactic acid bacteria not expressing trappin-2.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.06452
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14490161', '15565958', '11386159', '13143918', '14346488']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7221975736164958
- 35 USC 102 Novelty (BERT): 0.5118675610228333
- Combined Prediction Score: 0.7011645723571296
- Mean Citation Score: 190.622598
- Max Citation Score: 236.06543
- Similarity Product: 139.89715498404144

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test